Contact this trialFirst, we need to learn more about you.
Nonsteroidal Anti-inflammatory Drug
Aspirin for Prophylaxis of Preeclampsia
Recruiting5 awardsPhase 4
Peoria, Illinois
This is a study to assess if 162 mg of aspirin will decrease rates of preeclampsia in pregnant patients compared to 81 mg of aspirin.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.